These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 4789902)

  • 1. [The anti-tumor activity of several N-acetyl-sarcolysin derivatives in the form of non-aqueous solutions].
    Lopatin PV; Safonov VP; Litvinova TP
    Farmakol Toksikol; 1973; 26(4):479-80. PubMed ID: 4789902
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antineoplastic effect of asalin and asaleĭ during multiple and single enteral, intramuscular and rectal administration].
    Zaĭtseva LA; Borodkina RP; Lopatin PV; Syrkin AB
    Farmakol Toksikol; 1971; 34(4):460-3. PubMed ID: 5160789
    [No Abstract]   [Full Text] [Related]  

  • 3. [Obtaining and study of asalei and asalin suspensions].
    Lopatin PV; Borotkina RP; Badiàgin DA; Zaĭtseva LA; Syrkin AB
    Farmatsiia; 1971; 20(3):18-21. PubMed ID: 5567850
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the antitumor activity of sigma, N1N-bis(beta-chlorethyl)-L-lysine (lysepsis)].
    Snasskaia IG; Larionov LF
    Vopr Onkol; 1966; 12(9):66-70. PubMed ID: 6004071
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative study of the side effects of embikhin, sarcolysin and asalin].
    Sof'ina ZP
    Farmakol Toksikol; 1969; 32(3):312-6. PubMed ID: 5810949
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of benz(a)anthracene as an inductor of multipurpose oxidases on the toxic and antineoplastic effect of N,N-di-(2-chlorethyl)aniline].
    Belitskiĭ GA; Iaguzhinskiĭ LS
    Biull Eksp Biol Med; 1972 Jun; 73(6):72-4. PubMed ID: 5050592
    [No Abstract]   [Full Text] [Related]  

  • 7. [Distribution of asaphan-C14 in the organs of both sexes].
    Lobova TG; Sof'ina ZP
    Vopr Onkol; 1968; 14(10):79-82. PubMed ID: 5724802
    [No Abstract]   [Full Text] [Related]  

  • 8. [Vitamin B-12 in the chemotherapy of experimental tumors].
    Bulkina ZP; Poliak NR
    Vopr Onkol; 1968; 14(4):70-5. PubMed ID: 4969819
    [No Abstract]   [Full Text] [Related]  

  • 9. Research on compounds with antiblastic activity. XXX. p-(N,N-bis-(beta-chloroethyl)amino)benzylidene derivatives of some cyclopentanones.
    Giuliano R; Ermili A; Artico M; Grundmann E; Bierling R; Steinhoff D
    Farmaco Sci; 1967 Apr; 22(4):258-71. PubMed ID: 5608225
    [No Abstract]   [Full Text] [Related]  

  • 10. [Special combination of anticancer drug with its antidote for chemotherapy of hepatic metastasis in rat (author's transl)].
    Nishikawa K
    Fukuoka Igaku Zasshi; 1981 May; 72(5):290-9. PubMed ID: 7308960
    [No Abstract]   [Full Text] [Related]  

  • 11. [Kinetic growth curves of sarcoma 45 treated with alkylating agents].
    Kiseleva EG; Bogdanov GN; Konovalova NP; Emanuél' NM
    Izv Akad Nauk SSSR Biol; 1970; 4():530-4. PubMed ID: 5482749
    [No Abstract]   [Full Text] [Related]  

  • 12. [The protective effect of AET, cystamine and cystaphos when using lethal doses of antineoplastic drugs].
    Larionov LF; Spasskaia IG
    Vopr Onkol; 1968; 14(12):33-9. PubMed ID: 5714181
    [No Abstract]   [Full Text] [Related]  

  • 13. [Distribution of sarcolysin-C14 in the body of rats with sarcoma 45 and with drug-resistant variant of this tumor].
    NOVIKOVA MA
    Vopr Onkol; 1961; 7(3)():48-56. PubMed ID: 13729779
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of cyanocobalamin, cobamide coenzyme and the cytostatic hispen on changes in cobalamin levels in healthy rats and rats with transplanted sarcoma M-1].
    Brazhenas GR; Kanopkaĭte SI; Alenene AI; Aleksene AM
    Prikl Biokhim Mikrobiol; 1977; 13(1):65-73. PubMed ID: 866298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resarch on new Schiff bases with antiblastic activity. Carcinostatic activities of 3-p-(2',5'-dimethoxy-4'-(N,N-bis( -chloroethyl)-amino)benzylideneamino)phenyl-2-oxazolidinone (GEA 29 = BAY a 5850).
    Pütter J; Maral R; Bierling R; Steinhoff D
    Farmaco Sci; 1971 Sep; 26(9):784-804. PubMed ID: 5157546
    [No Abstract]   [Full Text] [Related]  

  • 16. [Role of immunity in the action of sarcolysine and other preparations].
    Syrkin AB; Solenov VN; Bodiagin DA; Zaĭtseva LA
    Vestn Akad Med Nauk SSSR; 1971; 26(3):55-9. PubMed ID: 5581445
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of serotonin on the antineoplastic activity and toxicity of sarcolysin and dopan].
    Mal'tseva LF
    Farmakol Toksikol; 1966; 29(6):698-701. PubMed ID: 6000367
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of various aminothiol compounds on the toxicity and specific activity of antitumor preparations].
    Spasskaia IG; Iurchenko NIa; Rachinskiĭ FIu
    Vopr Onkol; 1968; 14(10):75-9. PubMed ID: 5724801
    [No Abstract]   [Full Text] [Related]  

  • 19. [Regression of rat sarcoma 45 at single administration of sarcolysine, asalin and asalei].
    Syrkin AB; Solenov VN
    Farmakol Toksikol; 1969; 32(6):723-6. PubMed ID: 5381606
    [No Abstract]   [Full Text] [Related]  

  • 20. [The mechanism of tumor drug resistance].
    Kulik GI
    Vopr Onkol; 1969; 15(11):60-4. PubMed ID: 5368841
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.